5 November 2026
Sidley Represents Laza Medical in Its US$160 Million Series B Financing Round
Advising firms
Deal team
22 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Frank Rahmani Lead | Sidley | Not stated | Emerging Companies and Venture Capital | Not stated |
| Nick DeAngelis Lead | Sidley | Not stated | M&A | Not stated |
| Stephen M. Fronk Lead | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| Jake Funk | Sidley | Not stated | M&A | Not stated |
| Samantha Carvalho | Sidley | Not stated | M&A | Not stated |
| Laura DeMassa | Sidley | Not stated | M&A | Not stated |
| Becca Davis | Sidley | Not stated | M&A | Not stated |
| Dr. Idan Netser | Sidley | Not stated | Tax | Not stated |
| Nathan Enfield | Sidley | Not stated | Tax | Not stated |
| Nicholas Frey | Sidley | Not stated | Employee Benefits and Executive Compensation | Not stated |
| Rebecca Stuart | Sidley | Not stated | Labor, Employment and Immigration | Not stated |
| Jim Lowe | Sidley | Not stated | Antitrust and Competition | Not stated |
| Miriam Carroll Silvestri | Sidley | Not stated | Antitrust and Competition | Not stated |
| Diane McEnroe | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Emily Marden | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Jaclyn Fonteyne | Sidley | Not stated | Food, Drug and Medical Device | Not stated |
| Donielle McCutcheon | Sidley | Not stated | Healthcare | Not stated |
| Kim Schroer | Sidley | Not stated | Healthcare | Not stated |
| Sheri Porath Rockwell | Sidley | Not stated | Privacy and Cybersecurity | Not stated |
| Paul Kariyawasam | Sidley | Not stated | Technology and Life Sciences Transactions | Not stated |
| James Mendenhall | Sidley | Not stated | Global Arbitration, Trade and Advocacy | Not stated |
| Sarah Jehl | Sidley | Not stated | Environmental, Health and Safety | Not stated |
19 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 160m (US$160 million)
- What the figure measures
- Fund size
- Client
- Laza Medical, Inc.Issuer
- Counterparties
- GE HealthCare (Investor)
Unorthodox Ventures (Investor)
PA MedTech (Investor)
AMED (Investor)